Pneumococcal Vaccine Market Research 2024-2030: Prevnar 13, VAXNEUVANCE, PNEUMOSIL Size, Share & Trends Analysis
06. September 2024 07:17 ET
|
Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Global Pneumococcal Vaccine Market Size, Share & Trends Analysis Report by Vaccine Type, Product (Prevnar 13, VAXNEUVANCE, PNEUMOSIL), End-use...
Pneumococcal Vaccine Market Research Report 2024
03. September 2024 11:24 ET
|
Research and Markets
Dublin, Sept. 03, 2024 (GLOBE NEWSWIRE) -- The "Pneumococcal Vaccine Market Report by Vaccine Type, End User, and Region 2024-2032" report has been added to ResearchAndMarkets.com's offering.The...
Global Pneumococcal Vaccine Market Report 2022: Featuring GlaxoSmithKline, Merck, Pfizer, Sanofi & Others
26. September 2022 07:18 ET
|
Research and Markets
Dublin, Sept. 26, 2022 (GLOBE NEWSWIRE) -- The "Pneumococcal Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
United States Human Vaccines Market Report 2022: A Market Poised to Grow by $31.51 Bn by 2028 Featuring Sanofi Pasteur, Merck, Pfizer, Seqirus, AstraZeneca, Dynavax Technology, Emergent BioSolutions
27. Juni 2022 05:58 ET
|
Research and Markets
Dublin, June 27, 2022 (GLOBE NEWSWIRE) -- The "United States Human Vaccines Market Size, Share, Top 45 Human Vaccines Brand In-depth Analysis, Emerging Trends, Current Analysis, Growth, Demand,...
United States Vaccines Market Analysis and Forecasts, 2018-2020 & 2021-2027
02. Juli 2021 08:13 ET
|
Research and Markets
Dublin, July 02, 2021 (GLOBE NEWSWIRE) -- The "United States Vaccines Market Size, Top 45 Vaccines Brand In-Depth Analysis, Trends, Shares, Insights, and Forecasts to 2027" report has been added to...
Insights on the Pneumococcal Vaccine Global Market to 2026 - Competitive Analysis and the Impact of COVID-19
17. Juni 2021 06:38 ET
|
Research and Markets
Dublin, June 17, 2021 (GLOBE NEWSWIRE) -- The "Global Pneumococcal Vaccine Market (2021-2026) by type of the Vaccine, Product, Sectors, Distribution Channel, Geography, Competitive Analysis and the...
Global Pneumococcal Vaccines Disease Analysis Report 202: Overall Likelihood of Approval of a Phase I Pneumococcal Vaccine is 16.7%
09. April 2021 06:48 ET
|
Research and Markets
Dublin, April 09, 2021 (GLOBE NEWSWIRE) -- The "Disease Analysis: Pneumococcal Vaccines" report has been added to ResearchAndMarkets.com's offering. The value of the pneumococcal vaccines market...
Insights on the Pneumococcal Vaccine Global Market to 2025 - Competitive Analysis and the Impact of COVID-19
20. Januar 2021 06:13 ET
|
Research and Markets
Dublin, Jan. 20, 2021 (GLOBE NEWSWIRE) -- The "Global Pneumococcal Vaccine Market (2020-2025) by Type of Vaccine, Product, Sectors, Distribution Channel, Geography, Competitive Analysis and the...
Pneumococcal Vaccines Market, 2024 - Prevnar 13 / Pneumovax 23 / V114 / PF-06482077
16. Oktober 2020 05:38 ET
|
Research and Markets
Dublin, Oct. 16, 2020 (GLOBE NEWSWIRE) -- The "Pneumococcal Vaccines Market and Forecast Analysis to 2024" report has been added to ResearchAndMarkets.com's offering. The value of the pneumococcal...